Barry D Quart

Director

Barry D Quart (Director) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $836K of KNSA (20,129 sh × $41.51, as filed), executed Dec 15 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.6M

shares × price, as filed

Last traded

Apr 28

Filed Apr 29

Median ADV $60.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

KNSA

Kiniksa Pharmaceuticals International, plc KNSA · 0 buys · 6 sells 6 filings

Recent filings

KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $656K
13,099 sh × $50.10
Exec Apr 28
Filed Apr 29 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $345K
6,901 sh × $50.00
Exec Apr 6
Filed Apr 8 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $121K
2,690 sh × $45.00
Exec Feb 12
Filed Feb 12 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $684K
15,130 sh across 2 lots
Exec Feb 3
Filed Feb 4 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $836K
20,129 sh × $41.51
Exec Dec 15 2025
Filed Dec 17 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $833K
27,448 sh across 3 lots
Exec Jun 9 2025
Filed Jun 11 2025 · 5:30 PM ET